Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Clinical Immunology | Spotlight

In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes

Siroon Bekkering, Bastiaan A. Blok, Leo A. B. Joosten, Niels P. Riksen, Reinout van Crevel, Mihai G. Netea
H. F. Rosenberg, Editor
Siroon Bekkering
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bastiaan A. Blok
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
bResearch Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark
cOdense Patient Data Explorative Network, University of Southern Denmark/Odense University Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo A. B. Joosten
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels P. Riksen
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinout van Crevel
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mihai G. Netea
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. F. Rosenberg
IIS/LAD/NIAID/NIH
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00349-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Schematic overview of trained immunity methodology. Monocytes were trained for 2 h (2 hr-T), 4 h (4 hr-T), or 24 h (24 hr-T). After the training stimulus was washed away, the cells were rested for 24 h (24 h-R), 3 days (3d-R), or 6 days (6d-R), after which the cells were restimulated with RPMI, LPS, or Pam3Cys for 24 h.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. (A) IL-6 production after restimulation. Cells were trained for 2 h, 4 h, or 24 h with β-glucan, BCG, or oxLDL and rested for 24 h, 3 days (3d), or 6 days (6d). (B) TNF-α production after restimulation. Cells were trained for 2 h, 4 h, or 24 h with β-glucan, BCG, or oxLDL and rested for 24 h, 3 days, or 6 days. Shown are the fold changes compared to the results for the RPMI control (n = 6; ^, P = 0.06 compared to the RPMI control; *, P < 0.05 compared to the RPMI control; **, P < 0.01 compared to the RPMI control).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Trained immunity effects on cell morphology and numbers. (A) Morphology of cells after 24 h of training and 6 days of rest when the cells were trained with RPMI (negative control), β-glucan, BCG, or oxLDL. Pictures were taken before restimulation at day 6. Magnification, ×20. (B) Size of cells after 24 h of training and 6 days of rest before restimulation at day 6 (n = 3, *, P < 0.05; compared to the RPMI control; ***, P < 0.001 compared to the RPMI control). (C) Relative cell counts before restimulation at day 6 (n = 6; *, P < 0.05, compared to the RPMI control; ns, not significant). (D) IL-6 and TNF-α production after restimulation for corrected cell counts (n = 6; *, P < 0.05 compared to the RPMI control; **, P < 0.01 compared to the RPMI control).

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Anti-inflammatory cytokine production is increased in trained monocytes. (A) IL-10 production after restimulation. Cells were trained for 24 h with β-glucan, BCG, or oxLDL and rested for 6 days. The level of production of the anti-inflammatory cytokine IL-10 increased upon training. (B) IL-1Ra production. Cells were trained for 24 h with β-glucan, BCG, or oxLDL and rested for 6 days. The level of production of the anti-inflammatory cytokine IL-1Ra increased upon training not only after restimulation but also at the baseline (n = 6; ^, P = 0.06 compared to the RPMI control; *, P < 0.05 compared to the RPMI control; **, P < 0.01 compared to the RPMI control; ns, not significant). P3C, Pam3Cys.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    ROS production is a component of trained immunity for some stimuli. The level of ROS production was significantly increased for monocytes trained with BCG and oxLDL; training with β-glucan decreased the level of ROS production (n = 6; *, P < 0.05 compared to the RPMI control; ***, P < 0.001 compared to the RPMI control; ns, not significant). Cells were trained for 24 h using β-glucan, BCG, or oxLDL, and normalized cell numbers were restimulated using zymosan. Luminol was added, and luminescence was measured for 1 h. RLU/s, relative light units per second.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Trained immunity induction of glycolysis. Cells were trained for 2 h (2hr-T), 4 h (4hr-T), or 24 h (24hr-T) with RPMI (negative control), β-glucan, BCG, or oxLDL and rested for 24 h (24hr-R), 3 days (3d-R), or 6 days (6d-R). The level of lactate production in the supernatants was measured before restimulation (n = 6; *, P < 0.05 compared to the RPMI control; **, P < 0.01 compared to the RPMI control; ns, not significant).

Additional Files

  • Figures
  • Supplemental material

    • Supplemental file 1 -

      Fig. S1. Monocyte purity of different isolation steps. Fig. S2. Increased proinflammatory cytokine production is dependent on both training and resting time. Fig. S3. Training induces changes in cell morphology. Fig. S4. Anti-inflammatory cytokine production is increased in trained monocytes. Fig. S5. Morphological changes after 24 h of training and 6 days of resting persist after 24 h of restimulation.

      PDF, 2.5M

PreviousNext
Back to top
Download PDF
Citation Tools
In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes
Siroon Bekkering, Bastiaan A. Blok, Leo A. B. Joosten, Niels P. Riksen, Reinout van Crevel, Mihai G. Netea
Clinical and Vaccine Immunology Dec 2016, 23 (12) 926-933; DOI: 10.1128/CVI.00349-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes
Siroon Bekkering, Bastiaan A. Blok, Leo A. B. Joosten, Niels P. Riksen, Reinout van Crevel, Mihai G. Netea
Clinical and Vaccine Immunology Dec 2016, 23 (12) 926-933; DOI: 10.1128/CVI.00349-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X